Get alerts of updates about «Who will get the coronavirus vaccine?»
You have subscribed to alerts about:
Who will get the coronavirus vaccine?
Skip to content on this page
These will be offered a coronavirus vaccine:
By risk groups we mean people with an increased risk of a severe COVID-19 disease course. These include:
Residents in nursing homes
Everyone who is 65 years or older
People aged 12 years - 64 years with one or more defined diseases / conditions that increase the risk of a severe disease course and death from COVID-19. See the section below for specification of different diseases / conditions and age groups.
Healthcare personnel and other employees in the health and care service who have close contact with patients during treatment or care.
Everyone over and including the age of 12 years.
People with the following disease/ conditions are defined as medical risk groups:
- Organ transplant*
- Hematologic (blood) cancer in the last 5 years*
- Other active cancer, ongoing or recently finished treatment for cancer (especially immunosuppressive therapy, radiation therapy to the lungs or chemotherapy)*
- Neurological or muscular disease with impaired coughing strength or lung function (e.g., ALS and cerebral palsy)*
- Downs Syndrome*
- Chronic kidney disease or significantly impaired renal function
- Chronic liver disease or significantly impaired liver function
- Immunosuppressive therapy, e.g. with autoimmune diseases
- Chronic lung disease, including severe asthma that has required the use of high-dose inhaled steroids or steroid tablets during the last year
- Obesity with body mass index (BMI) of ≥ 35 kg/m2 or higher
- Chronic cardiovascular disease (except high blood pressure)
Other serious and / or chronic diseases may also increase the risk of a severe disease course.
* These diseases/ conditions can give a high risk for a severe disease course and death among younger people.
For more detailed information about diseases/conditions that can give an increased risk for a severe COVID-19 disease course see:
Getting the vaccine
The solutions used for appointments vary between municipalities. In some places, drop-in vaccination is available without the need for an appointment. Check your municipality's website for information about the local arrangements.
The vaccine is free.
People who belong to these groups and are resident or staying temporarily in Norway can have the vaccine as part of the immunisation programme.
Rationale for the recommendations to the different groups
Adults and adolescents aged 16-64 years are recommended two doses of coronavirus vaccine. From 65 years and older, it is recommended to give a booster dose at least 6 months after the second dose. The recommendation is primarily related to the risk of a severe COVID-19 disease course in these groups. It is the oldest, and people with certain diseases and conditions who have the greatest risk of a severe disease course and death from COVID-19 disease. Although most young and healthy people recover well from COVID-19, some in this group may also become seriously ill.
A small group of people with severe immune deficiency are recommended to have 3 doses because they have insufficient protection after the first two doses. In these cases, the third dose should be given at least 4 weeks after the second dose.
- Healthcare professionals who have contact with patients at particularly high risk of a severe disease course will also be offered a booster dose of coronavirus vaccine no earlier than 6 months after dose 2.
Pregnancy: The risk of a severe COVID-19 disease course among pregnant women is low. However, pregnant women still have a slightly higher probability of a severe disease course than non-pregnant women. The risk is highest in the last stage of pregnancy. The coronavirus vaccine is therefore recommended for pregnant women who are in their 2nd and 3rd trimester. Pregnant women with other underlying conditions (belonging to risk groups) can also be vaccinated in the 1st trimester. This is because the risk of a severe disease course will also be higher in the 1st trimester among those with underlying conditions.
Adolescents 12-15 years: All adolescents in this age group are offered one dose of coronavirus vaccine. This group rarely becomes seriously ill with COVID-19 disease. The direct medical benefit of the vaccine for the individual adolescent is less clear than for the older age groups who have a higher risk of serious illness. Some children and adolescents could still have a severe disease course. The offer of vaccination means that the individual has the opportunity to protect themselves through vaccination.
Children and adolescents with severe underlying diseases have a higher risk of severe COVID-19 disease course and coronavirus vaccine is recommended. They should have two doses.
Vaccination in all these groups will, in addition to protecting those who are vaccinated, also help to reduce transmission in society.
Read more about recommendations for adolescents aged 12-15: